European Court of Justice [0.03%]
欧洲法院
Herman Nys
Herman Nys
European Court of Justice [0.03%]
欧洲法院
An Baeyens
An Baeyens
What Healthcare Services Temporary Protection Entitles to Have? Navigating the European Social Charter [0.03%]
欧洲社会宪章规定的临时保护受益人享有哪些医疗服务？如何利用好这些服务？
Yana Litins&#x;ka
Yana Litins&#x;ka
Due to the war against Ukraine, the European Union Temporary Protection Directive, establishing a new migration status of temporary protection, was activated for the first time. The substance of the minimum requirement for providing healthc...
Genetics and Justice, Non-Ideal Theory and the Role of Patents: The Case of CRISPR-Cas9 [0.03%]
基因和正义，非理想理论与专利的作用——以CRISPR-Cas9为例
Oliver Feeney
Oliver Feeney
There are ongoing concerns of social justice regarding inequalities in the distribution of access to potential genome editing technologies. Working within non-ideal theory, Colin Farrelly advances a justification for the use of patents to s...
Judit Sandor
Judit Sandor
With the technical possibility of genome editing, we have reached a new phase of transforming human beings and even altering our genetic legacy. Genome editing constitutes new responsibilities in many fields. Science and society have never ...
The Application of EU Competition Law to the Exploitation of Human Genome Editing Technology [0.03%]
欧盟竞争法在人类基因编辑技术开发利用中的适用性研究
Vladimir Bastidas Venegas
Vladimir Bastidas Venegas
This paper explores the application of EU Competition Law to the exploitation of human genome editing technology. Holders of key patents in the sector have applied different methods for disseminating the technology, such as different forms ...
A Room with a View (and with a Gene Therapy Drug): Gene Therapy Medicinal Products and Genetic Tourism in Europe [0.03%]
兼具美景与基因治疗药物的房间——欧洲基因 therapy 药物和基因旅游透视
Vera Lúcia Raposo
Vera Lúcia Raposo
In contrast to the extreme caution that has been imposed on genetic medical procedures, in European law genetic drugs, or medications, have found a legal loophole that allows flexible (perhaps too flexible) access to these drugs. In Europe,...
Addressing Cognitive Vulnerabilities through Genome and Epigenome Editing: Techno-Legal Adaptations for Persons with Intellectual Disabilities [0.03%]
通过基因组和表观基因组编辑解决认知脆弱性：智力障碍者的技术法律适应措施
Pin Lean Lau
Pin Lean Lau
The key aim of this paper is to highlight the oft-under-represented narrative of how persons with disabilities (specifically, those with intellectual disabilities) may access the benefits that genome editing may offer. Firstly, this paper r...
Somatic Genome Editing with the Use of AI: Big Promises but Doubled Legal Issues [0.03%]
利用AI进行体细胞基因编辑：宏伟承诺与法律问题并存
Anastasiya Kiseleva
Anastasiya Kiseleva
Both Artificial Intelligence ('AI') and genome editing are technologies that on their own promise to revolutionise healthcare. But their common application can facilitate progress in the field even more. Multiplied benefits go along with in...
What Would It Take to Enable Germline Editing in Europe for Medical Purposes? [0.03%]
在欧洲为了医学目的启用体细胞基因组编辑需要什么条件？
Santa Slokenberga
Santa Slokenberga
Commonly, the regulation on germline editing in Europe is described through the two prohibitions: the prohibition set out in Article 13 of the Convention for the protection of Human Rights and Dignity of the Human Being with regard to the A...